atai Life Sciences (ATAI) Misses Q2 EPS by 1c

atai Life Sciences (NASDAQ: ATAI) reported Q2 EPS of ($0.24), $0.01 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $170 thousand, versus $0 reported last year.

For earnings history and earnings-related data on atai Life Sciences (ATAI) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Arrive AI and DXC Technology partner to bring delivery tech to factories
• B.Riley Assumes Anika Therapeutics (ANIK) at Buy